Protective effect of Humic acid against Diabetic Retinopathy in streptozotocin-induced diabetic rats

Year 2026, Volume: 46 Issue: 1, 27 - 38, 01.03.2026

Pratixa Patel , Arindam Paul

https://doi.org/10.52794/hujpharm.1697854

https://izlik.org/JA86AP38TF

Abstract

Diabetes mellitus (DM) is a growing global health concern, often leading to complications such as diabetic retinopathy (DR), primarily due to chronic hyperglycemia. DR is associated with oxidative stress, microvascular damage, and inflammation. Humic acid (HA), a natural polyphenolic antioxidant, has demonstrated free radical-scavenging properties. The purpose of this study was to evaluate the protective effect of HA against DR in streptozotocin (STZ) -induced diabetic rats. DR was induced with a single intraperitoneal dose of STZ (55 mg/kg). Diabetic rats were then treated orally with HA at 100, 500, and 1000 mg/kg for 90 days. Key parameters measured included blood glucose, HbA1c, body weight, total cholesterol (TC), triglycerides (TG) and retinal morphometry. HA treatment significantly reduced blood glucose levels, improved body weight, and normalized lipid profiles. It also lowered oxidative stress in ocular tissues by decreasing lipid peroxidation and enhancing antioxidant levels. Histological analysis revealed notable recovery of retinal structure following HA treatment. These findings suggest that HA exerts a protective effect against DR by improving metabolic balance, reducing oxidative stress, and preserving retinal integrity, thereby indicating its potential as a therapeutic agent in diabetes-related ocular complications.

Keywords

Diabetes mellitus , Diabetic retinopathy , Humic Acid (HA) , Antioxidant , in vivo

Project Number

1

References

• 1. Park YG, Roh YJ. New diagnostic and therapeutic approaches for preventing the progression of diabetic retinopathy. J Diabetes Res. 2016;2016:1753584. doi:10.1155/2016/1753584.
• 2. Roden M. Diabetes mellitus-definition, klassifikation und diagnose. Wien Klin Wochenschr. 2016;128(2):37–40. doi:10.1007/s00508-015-0931-3.
• 3. Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62:3–16. doi:10.1007/s00125-018-4711-2.
• 4. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843.
• 5. Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol. 2007;14:179–83. doi:10.1080/09286580701396720.
• 6. Guzman DC, Olguín HJ, García EH, Peraza AV, de la Cruz DZ, Soto MP. Mechanisms involved in the development of diabetic retinopathy induced by oxidative stress. Redox Rep. 2016;22(1):1–7. doi:10.1080/13510002.2016.1205303.
• 7. Cheloni R, Gandolfi SA, Signorelli C, Odone A. Global prevalence of diabetic retinopathy: protocol for a systematic review and meta-analysis. BMJ Open. 2019;9:e022188. doi:10.1136/bmjopen-2018-022188.
• 8. Kusuhara S, Fukushima Y, Ogura S, Inoue N, Uemura A. Pathophysiology of diabetic retinopathy: the old and the new. Diabetes Metab J. 2018;42:364–76. doi:10.4093/dmj.2018.0182.
• 9. Wang W, Lo ACY. Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci. 2018;19(6):1816. doi:10.3390/ijms19061816.
• 10. Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, Dohmen s, et al. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J. 2002;16:438–40. doi:10.1096/fj.01-0707fje.
• 11. Modak M, Dixit P, Londhe J, Ghaskadbi S, Devasagayam TPA. Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr. 2007;40(3):163–73. doi:10.3164/jcbn.40.163.
• 12. Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, et al. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci. 2007 Apr;62(4):427-33. doi: 10.1093/gerona/62.4.427.
• 13. Haskins K, Bradley B, Powers K, Fadok V, Flores S, Ling X, et al. Oxidative stress in type 1 diabetes. Ann N Y Acad Sci. 2003 Nov;1005:43-54. doi: 10.1196/annals.1288.006.
• 14. Hammes HP. Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond. Diabetologia. 2018 Jan;61(1):29-38. doi: 10.1007/s00125-017-4435-8.
• 15. Kowluru RA, Chan PS. Oxidative stress and diabetic retinopathy. Exp Diabetes Res. 2007;2007:43603. doi: 10.1155/2007/43603.
• 16. Kang Q, Yang C. Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications. Redox Biol. 2020 Oct;37:101799. doi: 10.1016/j.redox.2020.101799.
• 17. Anderson RE, Rapp LM, Wiegand RD. Lipid peroxidation and retinal degeneration. Curr Eye Res. 1984 Jan;3(1):223-7. doi: 10.3109/02713688408997203. PMID: 6606531.
• 18. Nazarian-Samani Z, Sewell RDE, Lorigooini Z, Rafieian-Kopaei M. Medicinal Plants with Multiple Effects on Diabetes Mellitus and Its Complications: a Systematic Review. Current Diabetes Reports. 2018 Aug 13;18(10). https://doi.org/10.1007/s11892-018-1042-0.
• 19. Hagura R. Diabetes mellitus and life-style--for the primary prevention of diabetes mellitus: the role of diet. Br J Nutr. 2000 Dec;84 Suppl 2:S191-4. doi: 10.1079/096582197388671. PMID: 11242468.
• 20. Efimova, I.V., Khil’ko, S.L. Smirnova, O.V. Antioxidant activity of humic acids in radical-chain oxidation processes. Russ J Appl Chem 85, 1351–1354 (2012). https://doi.org/10.1134/S1070427212090091.
• 21. Aeschbacher M, Graf C, Schwarzenbach RP, Sander M. Antioxidant properties of humic substances. Environ Sci Technol. 2012 May 1;46(9):4916-25. doi: 10.1021/es300039h. Epub 2012 Apr 13. PMID: 22463073.
• 22. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998 Sep 12;352(9131):837-53. Erratum in: Lancet 1999 Aug 14;354(9178):602. PMID: 9742976.
• 23. Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015 Sep 30;2:17. doi: 10.1186/s40662-015-0026-2. PMID: 26605370; PMCID: PMC4657234.
• 24. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005 Jun;54(6):1615-25. doi: 10.2337/diabetes.54.6.1615. PMID: 15919781.
• 25. Li Y, Cheng T, Wan C, Cang Y. circRNA_0084043 contributes to the progression of diabetic retinopathy via sponging miR-140-3p and inducing TGFA gene expression in retinal pigment epithelial cells. Gene. 2020 Jul 15;747:144653. doi: 10.1016/j.gene.2020.144653. Epub 2020 Apr 4. Erratum in: Gene. 2021 Oct 20;800:145789. doi: 10.1016/j.gene.2021.145789. PMID: 32259630.
• 26. Al-Kharashi AS. Role of oxidative stress, inflammation, hypoxia and angiogenesis in the development of diabetic retinopathy. Saudi J Ophthalmol. 2018 Oct-Dec;32(4):318-323. doi: 10.1016/j.sjopt.2018.05.002. Epub 2018 May 29. PMID: 30581303; PMCID: PMC6300752.
• 27. Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum? Indian J Endocrinol Metab. 2016 Jul-Aug;20(4):546-51. doi: 10.4103/2230-8210.183480. PMID: 27366724; PMCID: PMC4911847.
• 28. Hartenstein R. Sludge decomposition and stabilization. Science. 1981 May 15;212(4496):743-9. doi: 10.1126/science.212.4496.743. PMID: 17752228.
• 29. Pettit RE. Organic matter, humus, humate, humic acid, fulvic acid and humin. The Wonderful World of Humus and Carbon. 2006.
• 30. Gostishcheva MV. Chemical-pharmaceutical study of native humic acids from peats of Tomsk Oblast [dissertation]. Perm: Cand. Sci.; 2008.
• 31. Van Rensburg CEJ, Malfield SCK, Dekker J. Topical application of oxifulvic acid suppresses the cutaneous immune response in mice. Drug Dev Res. 2001;53:29–32. https://doi.org/10.1002/ddr.1166.
• 32. Van Rensburg CE, Dekker J, Weis R, Smith TL, Janse van Rensburg E, Schneider J. Investigation of the anti-HIV properties of oxihumate. Chemotherapy. 2002 Jul;48(3):138-43. doi: 10.1159/000064919. PMID: 12138330.
• 33. Thiel KD, Helbig B, Klöcking R, Wutzler P, Sprössig M, Schweizer H. Vergleich der in-vitro-Wirksamkeit von Ammoniumhumat und enzymatisch oxidierter Chlorogen- und Kaffeesäure gegenüber Herpesvirus hominis Typ 1 und 2 [Comparison of the in vitro activities of ammonium humate and of enzymically oxidized chlorogenic and caffeic acids against type 1 and type 2 human herpes virus (author’s transl)]. Pharmazie. 1981;36(1):50-3. German. PMID: 6261267.
• 34. Vucskits AV, Hullár I, Bersényi A, Andrásofszky E, Kulcsár M, Szabó J. Effect of fulvic and humic acids on performance, immune response and thyroid function in rats. J Anim Physiol Anim Nutr (Berl). 2010 Dec;94(6):721-8. doi: 10.1111/j.1439-0396.2010.01023.x. PMID: 21073632.
• 35. Bardini G, Rotella CM, Giannini S. Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and Beta-cell dysfunction on micro- and macrovascular complications. Rev Diabet Stud. 2012 Summer-Fall;9(2-3):82-93. doi: 10.1900/RDS.2012.9.82. Epub 2012 Nov 15. PMID: 23403704; PMCID: PMC3700021.
• 36. Kota SK, Meher LK, Jammula S, Kota SK, Krishna SV, Modi KD. Aberrant angiogenesis: The gateway to diabetic complications. Indian J Endocrinol Metab. 2012 Nov;16(6):918-30. doi: 10.4103/2230-8210.102992. PMID: 23226636; PMCID: PMC3510961.
• 37. Obasanmi G, Lois N, Armstrong D, Hombrebueno JMR, Lynch A, Chen M, et al. Peripheral Blood Mononuclear Cells from Patients with Type 1 Diabetes and Diabetic Retinopathy Produce Higher Levels of IL-17A, IL-10 and IL-6 and Lower Levels of IFN-γ-A Pilot Study. Cells. 2023 Jan 31;12(3):467. doi: 10.3390/cells12030467. PMID: 36766809; PMCID: PMC9913819.
• 38. Dimitrova G, Lutty GA. The role of retinal venous congestion in diabetic retinopathy. SN Compr Clin Med. Apr 2021; 3(20):1-7. http://dx.doi.org/10.1007/s42399-021-00809-3.
• 39. Yang F, Yu J, Ke F, Lan M, Li D, Tan K, et al. Curcumin Alleviates Diabetic Retinopathy in Experimental Diabetic Rats. Ophthalmic Res. 2018;60(1):43-54. doi: 10.1159/000486574. Epub 2018 Mar 29. PMID: 29597206.
• 40. Hao J, Zhang H, Yu J, Chen X, Yang L. Methylene Blue Attenuates Diabetic Retinopathy by Inhibiting NLRP3 Inflammasome Activation in STZ-Induced Diabetic Rats. Ocul Immunol Inflamm. 2019;27(5):836-843. doi: 10.1080/09273948.2018.1450516. Epub 2018 Apr 2. PMID: 29608341.
• 41. Romero-Aroca P, Baget-Bernaldiz M, Pareja-Rios A, Lopez-Galvez M, Navarro-Gil R, Verges R. Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory. J Diabetes Res. 2016;2016:2156273. doi: 10.1155/2016/2156273. Epub 2016 Sep 28. PMID: 27761468; PMCID: PMC5059543.
• 42. Patel P, Paul A. The anti‑cataract properties of humic acid on glucose‑induced cataracts in goat eye lenses. Discov Med. 2024;1:167. https://doi.org/10.1007/s44337-024-00183-8
• 43 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265-75. PMID: 14907713.
• 44. Heath RL, Packer L. Photoperoxidation in isolated chloroplasts. I. Kinetics and stoichiometry of fatty acid peroxidation. Arch Biochem Biophys. 1968 Apr;125(1):189-98. doi: 10.1016/0003-9861(68)90654-1. PMID: 5655425.
• 45. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121-6. doi: 10.1016/s0076-6879(84)05016-3. PMID: 6727660.
• 46. Soni NO. Antıoxıdant assay ın vıvo and vıtro. Int J Phytopharmacol. 5(1), 2014, 51-58.
• 47. Ellman GL. Tissue Sulfhydryl groups. Arch Biochem Biophys 1959;82:70-77.
• 48. Luna, L.G. Manual of histological staining methods of Armed forces institute of Pathology. 3rd Edn. McGraw Hill Book Company, New York. 1968. pp. 153-173.
• 49. Obrosova IG, Minchenko AG, Marinescu V, Fathallah L, Kennedy A, Stockert CM, et al. Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia. 2001 Sep;44(9):1102-10. https://doi.org/10.1007/s001250100631
• 50. Szot K, Góralczyk K, Michalska M, Veryho N, Chojnowski J, Ponikowska I, et al. The effects of humic water on endothelial cells under hyperglycemic conditions: inflammation-associated parameters. Environ Geochem Health. 2019 Jun 15;41(3):1577-82. https://doi.org/10.1007/s10653-018-0238-1
• 51. Yen CC, Lu FJ, Huang CF, Chen WK, Liu SH, Lin-Shiau SY. The diabetogenic effects of the combination of humic acid and arsenic: in vitro and in vivo studies. Toxicology letters. 2007 Aug 10;172(3):91-105. https://doi.org/10.1016/j.toxlet.2007.05.008